201 related articles for article (PubMed ID: 35171199)
1. Association of Annual N-Terminal Pro-Brain Natriuretic Peptide Measurements With Clinical Events in Patients With Asymptomatic Nonsevere Aortic Stenosis: A Post Hoc Substudy of the SEAS Trial.
Hadziselimovic E; Greve AM; Sajadieh A; Olsen MH; Kesäniemi YA; Nienaber CA; Ray SG; Rossebø AB; Willenheimer R; Wachtell K; Nielsen OW
JAMA Cardiol; 2022 Apr; 7(4):435-444. PubMed ID: 35171199
[TBL] [Abstract][Full Text] [Related]
2. Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction: The PARALLAX Randomized Clinical Trial.
Pieske B; Wachter R; Shah SJ; Baldridge A; Szeczoedy P; Ibram G; Shi V; Zhao Z; Cowie MR;
JAMA; 2021 Nov; 326(19):1919-1929. PubMed ID: 34783839
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of NT-proBNP and an adapted monin score in patients with asymptomatic aortic stenosis.
Farré N; Gómez M; Molina L; Cladellas M; Blé M; Roqueta C; Ascoeta MS; Comin-Colet J; Vila J; Bruguera J
Rev Esp Cardiol (Engl Ed); 2014 Jan; 67(1):52-7. PubMed ID: 24774264
[TBL] [Abstract][Full Text] [Related]
4. Is elevation of N-terminal pro-B-type natriuretic peptide at discharge associated with 2-year composite endpoint of all-cause mortality and heart failure hospitalisation after transcatheter aortic valve implantation? Insights from a multicentre prospective OCEAN-TAVI registry in Japan.
Mizutani K; Hara M; Nakao M; Okai T; Kajio K; Murakami T; Shibata T; Yoshiyama M; Naganuma T; Yamanaka F; Higashimori A; Tada N; Takagi K; Araki M; Ueno H; Tabata M; Shirai S; Watanabe Y; Yamamoto M; Hayashida K
BMJ Open; 2018 Aug; 8(8):e021468. PubMed ID: 30121598
[TBL] [Abstract][Full Text] [Related]
5. Left Ventricular Hypertrophy and Biomarkers of Cardiac Damage and Stress in Aortic Stenosis.
Stein EJ; Fearon WF; Elmariah S; Kim JB; Kapadia S; Kumbhani DJ; Gillam L; Whisenant B; Quader N; Zajarias A; Welt FG; Bavry AA; Coylewright M; Piana RN; Mallugari RR; Clark DE; Patel JN; Gonzales H; Gupta DK; Vatterott A; Jackson N; Huang S; Lindman BR
J Am Heart Assoc; 2022 Apr; 11(7):e023466. PubMed ID: 35301869
[TBL] [Abstract][Full Text] [Related]
6. The evolution and prognostic value of N-terminal brain natriuretic peptide in predicting 1-year mortality in patients following transcatheter aortic valve implantation.
Elhmidi Y; Bleiziffer S; Piazza N; Ruge H; Krane M; Deutsch MA; Hettich I; Voss B; Mazzitelli D; Lange R
J Invasive Cardiol; 2013 Jan; 25(1):38-44. PubMed ID: 23293174
[TBL] [Abstract][Full Text] [Related]
7. Impact of N-terminal pro-B-type natriuretic peptide response on long-term prognosis after transcatheter aortic valve implantation for severe aortic stenosis and heart failure.
Kaneko H; Hoelschermann F; Tambor G; Okamoto M; Neuss M; Butter C
Heart Vessels; 2019 May; 34(5):777-783. PubMed ID: 30443765
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide in Elderly Patients With Valvular Heart Disease.
Zhang B; Xu H; Zhang H; Liu Q; Ye Y; Hao J; Zhao Q; Qi X; Liu S; Zhang E; Xu Y; Gao R; Pibarot P; Clavel MA; Wu Y;
J Am Coll Cardiol; 2020 Apr; 75(14):1659-1672. PubMed ID: 32273031
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.
Anand IS; Rector TS; Cleland JG; Kuskowski M; McKelvie RS; Persson H; McMurray JJ; Zile MR; Komajda M; Massie BM; Carson PE
Circ Heart Fail; 2011 Sep; 4(5):569-77. PubMed ID: 21715583
[TBL] [Abstract][Full Text] [Related]
10. Long-term prognostic value and serial changes of plasma N-terminal prohormone B-type natriuretic peptide in patients undergoing transcatheter aortic valve implantation.
Ribeiro HB; Urena M; Le Ven F; Nombela-Franco L; Allende R; Clavel MA; Dahou A; Côté M; Laflamme J; Laflamme L; DeLarochellière H; DeLarochellière R; Doyle D; Dumont E; Bergeron S; Pibarot P; Rodés-Cabau J
Am J Cardiol; 2014 Mar; 113(5):851-9. PubMed ID: 24528616
[TBL] [Abstract][Full Text] [Related]
11. Prognostic utility of N-terminal pro B-type natriuretic peptide ratio in mixed aortic valve disease.
Bernard J; Jean G; Bienjonetti-Boudreau D; Jacques F; Tastet L; Salaun E; Clavel MA
Open Heart; 2023 Jul; 10(2):. PubMed ID: 37474135
[TBL] [Abstract][Full Text] [Related]
12. N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement.
Stähli BE; Gebhard C; Saleh L; Falk V; Landmesser U; Nietlispach F; Maisano F; Lüscher TF; Maier W; Binder RK
Catheter Cardiovasc Interv; 2015 Jun; 85(7):1240-7. PubMed ID: 25511571
[TBL] [Abstract][Full Text] [Related]
13. N-terminal pro-B-type natriuretic peptide is associated with clinical outcomes after transcatheter aortic valve replacement.
Yu J; Wang W
J Cardiothorac Surg; 2023 Oct; 18(1):286. PubMed ID: 37817246
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of the ASGARD risk score for safe monitoring in asymptomatic nonsevere aortic stenosis.
Hadziselimovic E; Greve AM; Sajadieh A; Olsen MH; Nienaber CA; Ray SG; Rossebø AB; Wachtell K; Dominguez H; Valeur N; Carstensen HG; Nielsen OW
Eur J Prev Cardiol; 2024 Feb; ():. PubMed ID: 38416125
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial.
Jering KS; Claggett BL; Pfeffer MA; Granger CB; Køber L; Lewis EF; Maggioni AP; Mann DL; McMurray JJV; Prescott MF; Rouleau JL; Solomon SD; Steg PG; von Lewinski D; Braunwald E
Circ Heart Fail; 2023 May; 16(5):e010259. PubMed ID: 37125529
[TBL] [Abstract][Full Text] [Related]
16. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA
JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400
[TBL] [Abstract][Full Text] [Related]
17. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
[TBL] [Abstract][Full Text] [Related]
18. Post-procedural N-terminal pro-brain natriuretic peptide predicts one-year mortality after transcatheter aortic valve implantation.
Vale NC; Campante Teles R; Madeira S; Brito J; Sousa Almeida M; Nolasco T; Abecasis J; Rodrigues G; Carmo J; Furstenau M; Ribeiras R; Neves JP; Mendes M
Rev Port Cardiol (Engl Ed); 2018 Jan; 37(1):67-73. PubMed ID: 29317115
[TBL] [Abstract][Full Text] [Related]
19. Elevated N-terminal pro C-type natriuretic peptide is associated with mortality in patients undergoing transcatheter aortic valve replacement.
Hu P; Chen H; Wang LH; Jiang JB; Li JM; Tang MY; Guo YC; Zhu QF; Pu ZX; Lin XP; Ng S; Liu XB; Wang JA
BMC Cardiovasc Disord; 2022 Apr; 22(1):164. PubMed ID: 35413789
[TBL] [Abstract][Full Text] [Related]
20. Association of Cardiac Biomarkers With Major Adverse Cardiovascular Events in High-risk Patients With Diabetes: A Secondary Analysis of the DECLARE-TIMI 58 Trial.
Zelniker TA; Wiviott SD; Mosenzon O; Goodrich EL; Jarolim P; Cahn A; Bhatt DL; Leiter LA; McGuire DK; Wilding J; Averkov O; Budaj A; Parkhomenko A; Ray KK; Gause-Nilsson I; Langkilde AM; Fredriksson M; Raz I; Sabatine MS; Morrow DA
JAMA Cardiol; 2023 May; 8(5):503-509. PubMed ID: 36857035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
